Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05932771
Other study ID # 18/SPS/059
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2019
Est. completion date April 30, 2023

Study information

Verified date June 2023
Source Liverpool John Moores University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aimed to investigate the effect of different doses of hydrolyzed collagen (HC) with resistance exercise (RE) on whole body collagen synthesis in healthy young and older males and females.


Description:

This study aimed to investigate the effect of different doses of hydrolyzed collagen (HC) with resistance exercise (RE) on whole body collagen synthesis in healthy young and older males and females. Healthy young and older males and females ingested 0 grams, 15 grams or 30 grams HC with 50 milligrams vitamin C 1h prior to performing four sets' barbell back-squat RE at 10-repetition maximum load, after which they rested for six hours. Blood samples were collected throughout each trial to analyse procollagen type Ⅰ N-terminal propeptide (PⅠNP, a biomarker of collagen synthesis) and β-isomerized C-terminal telopeptide of type I collagen (β-CTX, a biomarker of collagen breakdown) concentration, and the concentration of 18 amino acids that constitute collagen. This is the first study to investigate the combined effect of different doses HC with high-intensity RE on whole body collagen synthesis in healthy young and older men and women. If 30 grams HC intake with RE does augment collagen synthesis more than RE alone, this suggests that long-term HC intake with chronic RE would be beneficial for tendon health, because collagen is the most abundant protein in tendon.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date April 30, 2023
Est. primary completion date August 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - At least 12 months experienced in resistance exercise (regular back squat experience) - Free from musculoskeletal injury - Nullipara (a woman who has never given birth) (only for young female participatns) Exclusion Criteria: - Having a history of patellar tendon pathology - Vegan - Consumed nutritional supplements or medication purported to have beneficial effects on muscle-tendon properties (e.g. antioxidants, protein, etc.) - Had a sustained a lower limb injury in the previous six months - Smoker/vaper - <18 or >40 years old (only for young participants) - <40 ro >65 years old (only for older participants) - Having an irregular menstrual cycle (only for young female participants)

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Experimental: Consumption of three different doses of hydrolyzed collagen (HC) with reistance exercise
Each trial lasts for seven hours and while participants consumed HC, performed resistance exercise and rested, 10 x 5 mL blood samples were collected from a superficial forearm vein using a cannula. All trials were performed at the same time of day (08:00 - 15:00). Different doses of HC (0 grams, 15 grams and 30 grams) and 50 milligrams vitamin C were dissolved with 250 milliliter water in an opaque bottle. To match calories of 30 grams HC, 34.1 grams and 15.4 grams maltodextrin was used in 0 grams HC and 15 grams HC respectively. Also to mask any potential difference in HC doses, 4 grams non-caloric sweetener was used in all HC doses. The details of nutritoinal supplements used are as follows: Hydrolysed collagen (Myprotein, Cheshire, UK), Vitamin C powder (Holland and Barrett Retail Limited, Warwickshire, UK), Maltodextrin (Myprotein, Cheshire, UK), and Non-caloric sweetener (Truvia®, SilverSpoon, London, UK)
Experimental: Consumption of two different doses of hydrolyzed collagen (HC) with reistance exercise
Each trial lasts for seven hours and while participants consumed HC, performed resistance exercise and rested, 10 x 5 mL blood samples were collected from a superficial forearm vein using a cannula. All trials were performed at the same time of day (08:00 - 15:00). Different doses of HC (0 grams and 30 grams) and 50 milligrams vitamin C were dissolved with 250 milliliter water in an opaque bottle. To match calories of 30 grams HC, 34.1 grams maltodextrin was used in 0 grams HC. Also to mask any potential difference in HC doses, 4 grams non-caloric sweetener was used in all HC doses. The details of nutritoinal supplements used are as follows: Hydrolysed collagen (Myprotein, Cheshire, UK), Vitamin C powder (Holland and Barrett Retail Limited, Warwickshire, UK), Maltodextrin (Myprotein, Cheshire, UK), and Non-caloric sweetener (Truvia®, SilverSpoon, London, UK)

Locations

Country Name City State
United Kingdom Dr Rob Erskine Liverpool

Sponsors (2)

Lead Sponsor Collaborator
Rob Erskine University of East Anglia

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in a marker of collagen synthesis Serum procollagen type ? N-terminal propeptide (P?NP) concentrations were measured following 0 grams, 15 grams or 30 grams hydrolyzed collagen (HC) intake with resistnace exercise (RE) during all trials. at rest immediately prior to HC ingestion, 0.5-hour post RE, 1-hour post RE, 2-hour post RE, 4-hour post RE and 6-hour post RE
Primary Change in a marker of collagen breakdown Plasma ß-isomerized C-terminal telopeptide of type I collagen (ß-CTX) concentrations were measured following 0 grams, 15 grams or 30 grams hydrolyzed collagen (HC) intake with resistnace exercise (RE) during all trials. at rest immediately prior to HC ingestion and 6-hour post RE
Primary Changes in amino acids concentrations in blood Concentration of serum amino acids that constitute collagen was measured following 0 grams, 15 grams or 30 grams hydrolyzed collagen (HC) intake with resistnace exercise (RE) during all trials. at rest immediately prior to HC ingestion, 0.5-hour post HC ingestion, 1-hour post HC ingestion, 0.5-hour post RE, 1-hour post RE, 2-hour post RE, 4-hour post RE and 6-hour post RE
Secondary Estrogen concentrations in women in each trial Concentrations of estrogen (17ß-estradiol) was measured in each trial. at rest immediately prior to HC ingestion
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06059404 - Tailoring OT and RD Services for Home-delivered Meal Clients Phase 1
Completed NCT02814604 - FoodFLIP: Testing the Effectiveness of a Food Information App to Promote the Selection of Healthier Foods N/A
Recruiting NCT03335644 - The NutriNet-Santé Study
Completed NCT02773069 - The Church as a Bridge to Deliver Health Resources Via Telehealth N/A
Recruiting NCT04932785 - Regular vs. Clear Liquid Diet for Mild to Moderate Acute Pancreatitis N/A
Completed NCT04025060 - Reducing Sugar-sweetened Beverage Consumption Among Children N/A
Recruiting NCT05311436 - Nutri-CAP: Nutrition for Children, Adolescent Girls, and Pregnant Women in Slums of Dhaka City N/A
Withdrawn NCT05074108 - Mitigating and Preventing Disordered Eating in Transitioning Service Members N/A
Active, not recruiting NCT05747066 - Nutrition in People With a Lower Limb Amputation
Completed NCT05605483 - Salad Bars in the National School Lunch Program: Impact on Dietary Consumption Patterns in Elementary School Students
Completed NCT03248115 - Bioavailability of Green Tea and Coffee Polyphenols N/A
Completed NCT02800564 - Change in Child-feeding Knowledge, Attitudes, and Practices With Nutrition Education Mass Media in Ghana N/A